Stay updated on Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the full study details with a minimal error screen. This indicates the ClinicalTrials.gov record for NCT03220477 is not accessible at this time.
    Difference
    19%
    Check dated 2026-09-20T20:08:03.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The study page now includes new related topic links under MedlinePlus Genetics, including Lung cancer. These additions provide quick access to educational resources related to the condition.
    Difference
    0.2%
    Check dated 2026-09-06T22:31:22.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page now displays a new Revision: v3.6.6 tag. The topic labels were updated to remove Lung cancer, related topics:, MedlinePlus Genetics, and Revision: v3.6.5.
    Difference
    0.2%
    Check dated 2026-08-30T21:54:11.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    A new Revision: v3.6.5 label appears on the page. Several elements from the previous revision, including site listings, collaborator and sponsor details, and metadata such as dates and revision notes, have been removed or updated to reflect the new revision.
    Difference
    17%
    Check dated 2026-08-09T11:10:36.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page's revision indicator was updated to v3.6.4, signaling a minor update to the page rather than substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-07-25T18:09:30.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Lung cancer and MedlinePlus Genetics were added under the related topics section to provide additional background links. This helps readers access background information about the condition and genetics resources.
    Difference
    0.2%
    Check dated 2026-07-18T15:50:37.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial page.